BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11588044)

  • 1. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
    Bleesing JJ; Brown MR; Straus SE; Dale JK; Siegel RM; Johnson M; Lenardo MJ; Puck JM; Fleisher TA
    Blood; 2001 Oct; 98(8):2466-73. PubMed ID: 11588044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
    Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
    Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
    Magerus-Chatinet A; Stolzenberg MC; Loffredo MS; Neven B; Schaffner C; Ducrot N; Arkwright PD; Bader-Meunier B; Barbot J; Blanche S; Casanova JL; Debré M; Ferster A; Fieschi C; Florkin B; Galambrun C; Hermine O; Lambotte O; Solary E; Thomas C; Le Deist F; Picard C; Fischer A; Rieux-Laucat F
    Blood; 2009 Mar; 113(13):3027-30. PubMed ID: 19176318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.
    Fleisher TA; Straus SE; Bleesing JJ
    Curr Allergy Asthma Rep; 2001 Nov; 1(6):534-40. PubMed ID: 11895618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
    Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
    Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
    J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological findings in human autoimmune lymphoproliferative syndrome.
    Lim MS; Straus SE; Dale JK; Fleisher TA; Stetler-Stevenson M; Strober W; Sneller MC; Puck JM; Lenardo MJ; Elenitoba-Johnson KS; Lin AY; Raffeld M; Jaffe ES
    Am J Pathol; 1998 Nov; 153(5):1541-50. PubMed ID: 9811346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis.
    Bleesing JJ; Brown MR; Dale JK; Straus SE; Lenardo MJ; Puck JM; Atkinson TP; Fleisher TA
    Clin Immunol; 2001 Sep; 100(3):314-24. PubMed ID: 11513545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).
    Vacek MM; Schäffer AA; Davis J; Fischer RE; Dale JK; Adams S; Straus SE; Puck JM
    Clin Immunol; 2006 Jan; 118(1):59-65. PubMed ID: 16257267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndrome.
    Goldman FD; Vibhakar R; Puck JM; Straus SE; Ballas ZK; Hollenback C; Loew T; Thompson A; Song K; Cook RT
    Clin Immunol; 2002 Jul; 104(1):31-9. PubMed ID: 12139945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
    Straus SE; Jaffe ES; Puck JM; Dale JK; Elkon KB; Rösen-Wolff A; Peters AM; Sneller MC; Hallahan CW; Wang J; Fischer RE; Jackson CE; Lin AY; Bäumler C; Siegert E; Marx A; Vaishnaw AK; Grodzicky T; Fleisher TA; Lenardo MJ
    Blood; 2001 Jul; 98(1):194-200. PubMed ID: 11418480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next Generation Sequencing for Detecting Somatic
    López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
    Front Immunol; 2021; 12():656356. PubMed ID: 33995372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
    Jackson CE; Fischer RE; Hsu AP; Anderson SM; Choi Y; Wang J; Dale JK; Fleisher TA; Middelton LA; Sneller MC; Lenardo MJ; Straus SE; Puck JM
    Am J Hum Genet; 1999 Apr; 64(4):1002-14. PubMed ID: 10090885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
    Rensing-Ehl A; Völkl S; Speckmann C; Lorenz MR; Ritter J; Janda A; Abinun M; Pircher H; Bengsch B; Thimme R; Fuchs I; Ammann S; Allgäuer A; Kentouche K; Cant A; Hambleton S; Bettoni da Cunha C; Huetker S; Kühnle I; Pekrun A; Seidel MG; Hummel M; Mackensen A; Schwarz K; Ehl S
    Blood; 2014 Aug; 124(6):851-60. PubMed ID: 24894771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.
    Bettinardi A; Brugnoni D; Quiròs-Roldan E; Malagoli A; La Grutta S; Correra A; Notarangelo LD
    Blood; 1997 Feb; 89(3):902-9. PubMed ID: 9028321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome.
    Bleesing JJ; Brown MR; Novicio C; Guarraia D; Dale JK; Straus SE; Fleisher TA
    Clin Immunol; 2002 Jul; 104(1):21-30. PubMed ID: 12139944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.
    Jackson CE; Puck JM
    Curr Opin Pediatr; 1999 Dec; 11(6):521-7. PubMed ID: 10590910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.
    Infante AJ; Britton HA; DeNapoli T; Middelton LA; Lenardo MJ; Jackson CE; Wang J; Fleisher T; Straus SE; Puck JM
    J Pediatr; 1998 Nov; 133(5):629-33. PubMed ID: 9821419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
    Straus SE; Sneller M; Lenardo MJ; Puck JM; Strober W
    Ann Intern Med; 1999 Apr; 130(7):591-601. PubMed ID: 10189330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
    Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
    Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.